iifl-logo-icon 1

ANG Lifesciences India Ltd Share Price

51.34
(-1.99%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open52.38
  • Day's High52.38
  • 52 Wk High86.06
  • Prev. Close52.38
  • Day's Low51.1
  • 52 Wk Low44.49
  • Turnover (lac)3.14
  • P/E0
  • Face Value10
  • Book Value59.02
  • EPS0
  • Mkt. Cap (Cr.)67.04
  • Div. Yield0
No Records Found

ANG Lifesciences India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

52.38

Prev. Close

52.38

Turnover(Lac.)

3.14

Day's High

52.38

Day's Low

51.1

52 Week's High

86.06

52 Week's Low

44.49

Book Value

59.02

Face Value

10

Mkt Cap (₹ Cr.)

67.04

P/E

0

EPS

0

Divi. Yield

0

ANG Lifesciences India Ltd Corporate Action

5 Sep 2023

12:00 AM

BookCloser

arrow

24 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

5 Sep 2023

12:00 AM

AGM

Announcement Date: 05 Sep, 2023

arrow

ANG Lifesciences India Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

ANG Lifesciences India Ltd SHAREHOLDING SNAPSHOT

17 Jul, 2024|12:03 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.60%

Foreign: 0.00%

Indian: 70.60%

Non-Promoter- 29.39%

Institutions: 0.00%

Non-Institutions: 29.39%

Custodian: 0.00%

Share Price

ANG Lifesciences India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

17.75

15.06

6.63

5.18

Preference Capital

0

0

0

0

Reserves

67.79

68.42

34.72

29.37

Net Worth

85.54

83.48

41.35

34.55

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

154.37

126.83

121.69

76.04

yoy growth (%)

21.72

4.21

60.03

12.37

Raw materials

-103.96

-88.96

-87.84

-52.89

As % of sales

67.34

70.14

72.17

69.55

Employee costs

-13.67

-7.93

-6.39

-5.64

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

10.13

8.4

8.1

4.95

Depreciation

-1.31

-1.22

-1.12

-1.19

Tax paid

-3.11

-2.31

-2.45

-1.22

Working capital

19.15

4.18

12.01

8.57

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

21.72

4.21

60.03

12.37

Op profit growth

14.75

6.52

61.15

12.43

EBIT growth

16.24

7.86

59.96

22.36

Net profit growth

15.28

7.9

51.68

31.89

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

146.11

219.89

354.3

154.38

Excise Duty

0

0

0

0

Net Sales

146.11

219.89

354.3

154.38

Other Operating Income

0

0

0

0

Other Income

0.7

9.72

0.9

0.56

ANG Lifesciences India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT ANG Lifesciences India Ltd

Management

Register Office

Registrar Office

Managing Director

Rajesh Gupta

Whole Time Director & CFO

Saruchi Gupta

Independent Director

Sukhpal Singh

Director

Sudesh Kumari

Independent Director

Pawanjit Singh

Independent Director

Chetna

Company Sec. & Compli. Officer

Renu

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to ANG Lifesciences India Limited on May 18, 2016.The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These state-of-art facilities have integrated process development teams with in-house engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It al
Read More

Company FAQs

What is the ANG Lifesciences India Ltd share price today?

Down Arrow

The ANG Lifesciences India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹51.34 today.

What is the Market Cap of ANG Lifesciences India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd is ₹67.04 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of ANG Lifesciences India Ltd?

Down Arrow

The PE and PB ratios of ANG Lifesciences India Ltd is 0 and 0.87 as of 16 Jul ‘24

What is the 52 Week High and Low of ANG Lifesciences India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a ANG Lifesciences India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of ANG Lifesciences India Ltd is ₹44.49 and ₹86.06 as of 16 Jul ‘24

What is the CAGR of ANG Lifesciences India Ltd?

Down Arrow

ANG Lifesciences India Ltd's CAGR for 5 Years at 27.00%, 3 Years at -14.25%, 1 Year at -22.54%, 6 Month at -25.88%, 3 Month at -9.12% and 1 Month at -2.15%.

What is the shareholding pattern of ANG Lifesciences India Ltd?

Down Arrow

The shareholding pattern of ANG Lifesciences India Ltd is as follows:
Promoters - 70.60 %
Institutions - 0.00 %
Public - 29.40 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.